Corporate Headquarters
441 Vine Street
Suite 1200
Cincinnati, OH 45202
Tel: 1 800 733 1572 (in US only)
Tel: +1 513 381 5550
Fax: +1 513 381 5870

I need a company that operates successfully out of Africa

While Africa has recently come to the forefront as the next ascending region in which to conduct clinical trials, it has been building its infrastructure for nearly three decades. The market potential for pharmaceuticals in Africa has been estimated at nearly $7.0 billion and its infrastructure is equivalent to other economically developed countries.

One of the main reasons for using Africa to conduct clinical trials is the typically fast enrollment in the region. Add this to the fact that approval for conducting a clinical trial in Africa is estimated at 12–14 weeks and you have an extremely favorable region in terms of clinical trial activity.

From our office base in Johannesburg, South Africa, our project leaders manage projects in other African countries in the private, academic and rural sectors. We offer clinical development services in Phases I–IV and undertake monitoring of donor-funded work. Our knowledge of donor-funding mechanisms for clinical research in the HIV arena especially ensures that projects are managed in accordance with applicable U.S. and South Africa regulations.

Top reasons to conduct a clinical trial in Africa

1. Fast enrollment – often overtaking other countries within a very short period of time.
   
   
2. ICH–GCP compliant – work in accordance with ICH–GCP principles.
   
   
3. Low cost – conducting a clinical trial in Africa will cost approximately 30 percent less than running the same study in the United States or Europe.
   
   
4. Seasonal reversal – Africa has reverse seasons to the Northern Hemisphere, shortening timelines for seasonal allergy or seasonal infection studies.
   
   
5. Numerous sites – more than 3,000 qualified clinical research sites.